Justine Aaronson - internationalbrain.org · Justine Aaronson Participant has no ... Dr. Silke Bernert, ... Dr. Shane S. Bush, ...

Justine Aaronson

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Hosam M. Al-Jehani, MBBS, MSc, FRCSC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MS Michelle Sarah Albicini, BPsych (Hons)

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Debra Geraldine Alexander, PhD; MSOC SC Clinical Psychology

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Yvette Alway

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Nada Andelic, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. David B. Arciniegas, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will discuss zolpidem treatment of disorders of consciousness.

Prof Philippe Azouvi, MD, PhD

Participant discloses the following financial or non-financial relationships:

1. Allergan: funding for travel accomodation (congress)

Participant has indicated no discussion of unapproved drug or product uses.

Prof Philippe Azouvi

Participant discloses the following financial or non-financial relationships:

1. Allergan: support for congress registration, accommodation and journey

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Shaylea Badovinac

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ryan Bailey, PhD, OTR/L

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Georgy Bakalkin, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mark Theodore Bayley, MD, FRCPC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Simon Beaulieu-Bonneau

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gary M. Bedell, PhD, OTR/L

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Silke Bernert, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jennifer Bogner, PhD, ABPP, FACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lisa Brenner

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Steven P Broglio, PhD, ATC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr David Neil Brooks, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Megan Leanne Bruschetta

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Shane S. Bush, PhD, ABPP

Participant discloses the following financial or non-financial relationships:

1. Springer publishing: Royalties

Participant has indicated no discussion of unapproved drug or product uses.

Tamara Bushnik, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Johannes Bussmann, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Anne Marie Buunk, MSc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. dr. Frans C. T. van der Helm, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Enrico Castelli, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

dr Coriene Catsman-Berrevoets

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Vincy Chan, MPH, PhD Candidate

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sebastien F Chastin

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Camille Chatelle, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Pearl Chung, M.B.B.S., B.Med.Sci., M.P.H.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Keith Cicerone, PhD, ABPP-Cn, FACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr David Xavier Cifu, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MSc. Maryse Catharina Cnossen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. John D. Corrigan, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Louise Cottle

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Nikola Creasey

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Christine Croisiaux

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

i totally agree to indicate unlabled and unapproved uses

Dr Will Curvis, Doctorate in Clinical Psychology

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Kristen Dams-O'Connor

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rita Liliana de Campos-Pires Santos e Sousa, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jurriaan De Groot

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Arend de Kloet

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Peter de Koning, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Erwin De Vlugt

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Carol Di Perri

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Robert Dickinson

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Dara L Dickstein

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Marcel P.J.M. Dijkers, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

PhD Sureyya Dikmen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Thomas P Dompier, PhD, ATC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Jacinta Douglas, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Dimitrios Drougkas, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will refer to the use of transcranial Direct Current Stimulation (tDCS) as an experimental (unlabeled by the

FDA) neurological treatment for Disorders of Consciousness

Dr Nicholas-Tiberio Economou, M.D., MSci, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Henk Jan Eilander, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Cathrine Elisabeth Einarsen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Michael Esterman

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Anna Estraneo

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Linda Ewing-Cobbs, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Philippe Fait, PhD, ATC, CAT(C)

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Joseph J. Fins, M.D., M.A.C.P.

Participant discloses the following financial or non-financial relationships:

1. Cambridge University Press: Book royalties for "Rights Come to Mind: Brain Injury Ethics and the Struggle for

Consciousness"

Participant has indicated the following discussion of unapproved drug or product uses:

Discuss investigational use of deep brain stimulation in MCS under an FDA approved IDE. See Schiff et al

Nature 2007

Prof. Dr. Stefan Ioan Florian

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Kelly Foks, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

dR Rita Formisano

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Rob Forsyth, PhD FRCPCH BM BCh

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Catherine Fortier, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Louis French, Psy.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Valentina Galetto, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Irene Galligan, MISCP

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Sam Gandy, M.D., Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will describe the research use of a new PET ligand, T807.

Dr. Joseph Giacino, PhD, FACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ann Elizabeth Glang, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jolien Gooijers

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kate Rachel Gould, DPsych

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Juliet Haarbauer-Krupa, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Biju Hameed, MRCPI MRCPCH PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

The work presented is on the potential neuroprotective effect of steroid receptor antagonists in experimental

models of head injury which include spironolactone and mifepristone, drugs in common use for other

indications.

Dr Firdaus Hariri, MBBS, BDS, MDS(OMFS)

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Tessa Hart, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Karameh Hawash Kuemmerle

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Carol Hawley, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Claire Hedley

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lizette Heine, M.Sc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Allen Heinemann, PhD

Participant discloses the following financial or non-financial relationships:

1. Patient-Centered Outcomes Research Institute (PCORI) Program Award (4201) : Award Winner

Participant has indicated no discussion of unapproved drug or product uses.

Ms Kathy Marie Helmick, MS, CRNP, ANP-BC, CNRN

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sidney R Hinds, II, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Erin M Holcomb, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Mark Holloway, DipSW MA

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Frank Humle, Director, Neuropsychologist

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Tamerah Hunt

Participant discloses the following financial or non-financial relationships:

1. SLACK, Incorporated: Author

2. USA Football: Serve on the medical advisory board

3. Centers for Disease Control- Nationwide Children's Hospital: Grant recipient

4. National Operating Committee for the Standards of Athletic Equipment (NOCSAE): Grant recipient

Participant has indicated no discussion of unapproved drug or product uses.

Mary Alexis Iaccarino, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gabriela Ilie, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Harri Isokuortti

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Grant L Iverson, PhD

Participant discloses the following financial or non-financial relationships:

1. NeuroHealth Research and Rehabilitation, Inc.: Independent Practice, Expert Testimony, Consulting

2. NeuroHealth, LLC: Independent Practice, Expert Testimony, Consulting

Participant has indicated no discussion of unapproved drug or product uses.

Dr Peter Owen Jenkins, MA, BMBCh

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Holly Brugge Jimison, PhD, FACMI

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will reference any unlabeled/unapproved uses of products. I will not discuss any drugs.

MS Cathy Johnson, B.Sc.,Dip.A.S.S.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ricardo Jorge

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Claire Jourdan, MD, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mladen Karan, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ahmed A. Karim

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Rune Hatlestad Karlsen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

.

Douglas I Katz, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Amantadine use in patients with DOC

Dr Heather Keenan, MDCM, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Zachary Y Kerr, PhD, MPH

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Bilal Khokhar

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Verena Klamroth-Marganska

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

As I do not work in the US, the product is not FDA certified. instead, I received permission by Swissmedic (the

Swiss agency for the authorisation and supervision of therapeutic products).

Ingerid Kleffelgaard, P.T., MSc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sanna Koskinen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Robert G. Kowalski, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

dr Odile Kozlowski Moreau, doctor of physical medicine and

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Denise Krch, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ryan C Kruse

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Wolfgang Kuehne

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. med. Martin Kulla, M.D. DESA

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ulrich Kunz

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Marsh Königs, MSc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Marie-Eve Lamontagne, O.T.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Yes, I intend to reference unlabeled/unapproved uses of drugs or products in my presentation and I agree to

disclose this information to the audience as required by accreditation guidelines.

Amaud Lanthier

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Anne Laurent-Vannier, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Pr. Steven Laureys, M.D.

Participant discloses the following financial or non-financial relationships:

1. Cefaly: Funding

2. G-Tec: Funding

3. Imagilys: Funding

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jan Lavrijsen, M.D., PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Leon Levi, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Harvey Levin

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Teemu Luoto, M.D. , Ph.D. , Adjunct professor

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Andrew Maas, M.D., PhD

Participant discloses the following financial or non-financial relationships:

1. European Commission, FP-7 framework programme: CENTER-TBI study; grant number 602150-2.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Linda McArthur Maclean, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Veronica Maki-Marttunen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Saafan Malik, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Jennifer Marwitz, M.A.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Simon Robert Mayer

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Michael Christian Mayinger, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Mazlina Mazlan, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Nicole Mazwi, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Thomas W. McAllister, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

methylphenidate, galantamine

Michael McCrea

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Karen Leigh McCulloch, PT, PhD, NCS

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Brenna McDonald

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Skye McDonald

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Regina McGlinchey, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Hamish McLeod, PhD CPsychol

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Tom McMillan

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Carel G.M. Meskers

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Peter Meulenbroek, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Maarten Milders

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Mehrbod Mohammadian

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Tatyana Mollayeva, MD, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Martin M Monti, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Daniel Morris

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Risa Nakase-Richardson, PhD, FACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Ponnada Narayana, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Vairavan Narayanan, M.D, FRCSEd (NeuroSurg)

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Karen J. Nolan, PhD

Participant discloses the following financial or non-financial relationships:

1. Ekso Bionics, Inc.: Advisory Board 6-2015

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Rocio Norman, M.A. CCC-SLP

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lyubov Borisovna Oknina, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Berno Overbeek

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Llewellyn Padayachy

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Marco YC Pang

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Theresa Pape, Dr.Ph

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Misha Pavel

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Yuri G. Pavlov

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Arwen Pel

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Lianne Peppel, MSc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Jennie Louise Ponsford, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Light therapy for fatigue and melatonin for sleep disturbance following traumatic brain injury

Mr. Shaun Porter, BSc.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Ingrid Poulsen, R.N.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Graham Edward Powell

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Aidanas Preiksaitis

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Cathy J Price, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Leslie S Prichep, PhD

Participant discloses the following financial or non-financial relationships:

1. BrainScope Co., Inc.: I serve as Chief Scientific Officer of BrainScope Co., Inc

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kate Radford, PhD, MSc. DipCOT

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Vani Rao, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Lukas Rasulic, M.D. PhD.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Amit Reches, PhD

Participant discloses the following financial or non-financial relationships:

1. ElMindA: Employee

Participant has indicated no discussion of unapproved drug or product uses.

Gerard M Ribbers, MD, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr David Ripley, MD, MS

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Cecilie Roe

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Karen G Roos, PhD, MSPT, ATC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Hemda Rotem

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kresimir Rotim

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Marc Rousseaux, M.D., Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Durga Roy, MD

Participant discloses the following financial or non-financial relationships:

1. ImmunArray : I am a Co-Investigator on the ImmunArray sponsored study Head Injury Serum Markers for

Assessing Response to Trauma (HeadSMART): IRB00031097

Participant has indicated no discussion of unapproved drug or product uses.

Dr Peter Rumney, MD, FRCPC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Tomislav Sajko

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

David Salat

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rajeet Singh Saluja, MD,CM, FRCSC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Angelle M. Sander, Ph.D., ACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jaana Maria Sarajuuri, PhD (c)

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Myrthe Elisabeth Scheenen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Nicholas D Schiff, MD

Participant discloses the following financial or non-financial relationships:

1. Enspire DBS, INc: Scientific Advisory Board

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Caroline Schnakers, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Alfred C. Schouten

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Trine Schow, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Gregory Scott, MBBS MSc BEng

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ronald Thomas Seel, PhD, FACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ruud W. Selles

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Zhanna Semenova, etc, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Mrs Aruna Sharma, MBBS, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Bhanu Sharma

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. David J Sharp, MBBS PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sandy Shultz, PhD, MSc, BSc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

A/Prof Grahame K Simpson, MAASW MAPS

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. William Davis Singer, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Amantadine is not FDA approved for the purpose of this presentation

Elizabeth R. Skidmore, PhD

Participant discloses the following financial or non-financial relationships:

1. San Bio, Inc.: Research Consultant

2. RAND Corporation: Research Consultant

Participant has indicated no discussion of unapproved drug or product uses.

Professor Mark Anthony Slatyer, B.Med Sci (Hons), B.Med,PhD (Med

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Semyon Slobounov

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Agaath Sluijter

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jonathan David Smirl, PhD.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Katherine Price Snedaker, LCSW

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Traci Snedden, PhD, RN, CPNP

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Kerstin Spielmann

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

professor dr. Jacoba Margje Spikman, PhD, Clinical Neuropsychologist

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Gershon Spitz, BA, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Dick F. Stegeman, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Joel D Stitzel, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Irina Strigo, Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jacek Szczygielski, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Sharon Tamir

Participant discloses the following financial or non-financial relationships:

1. Karyopharm Therapeutics: Employee

Participant has indicated the following discussion of unapproved drug or product uses:

KPT-350

Olli Tenovuo

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

dr Bert Ter Mors, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will discuss the investigational use of amantadine in brain injury. For this indication it is off-label use.

(amantadine is approved for the use in influenza-A and Parkinsons disease)

Miss Danielle Tessier

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Aurore Thibaut

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will talk about transcranial direct current stimulation (tDCS) which is not FDA approved.

Dr. Marleen C Tjepkema-Cloostermans

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Leanne Togher

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Luigi Trojano

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jean Luc Truelle, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. David Tulsky, Ph.D.

Participant discloses the following financial or non-financial relationships:

1. TBI-QOL Measures: Copyright holder (non-financial)

2. PROMIS Health Organization: Board of Directors

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ursula I. Tuor, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lyn Turkstra, Ph.D., CCC-SLP, BC-ANCDS

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lynne Turner-Stokes

Participant discloses the following financial or non-financial relationships:

1. Research grant funding: The work n my presentation was funded by a research grant from the NIHR RP-PG-

0407-10185

2. Honoraria: I have received honoraria and lectures fees from Ipsen Pharma

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Andy Tyerman, B.A., M.Sc. Ph.D., C.Psychol.

Participant discloses the following financial or non-financial relationships:

1. Andy Tyerman: Self

2. Ruth Tyerman : Wife

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gary R Ulicny, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Sebastian van As, Prof, MBChB MBA MMed FCS(SA) PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Coen A.M. van Bennekom, MD, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Crispijn L van den Brand

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MD Hans van der Horn

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Joukje van der Naalt, M.D. Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Rick Van der Vliet

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Willemijn Sabien van Erp, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Thomas A. Van Essen, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Judith Van Velzen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Erwin van Wegen

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Inge Verlinden

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Anderson Anne Vicki

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Eirik Vikane, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Martie Vink

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Naznin Virji-Babul, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Marieke M Visser, MSc

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

NA

Dr Victor Volovici, MD

Participant discloses the following financial or non-financial relationships:

1. European Comission Framework 7 Programme: Funding for the department of neurosurgery through the

CENTER-TBI project

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Petar Vulekovic, M.D. Ph.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Amy Kathllen Wagner, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lorna Wales

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Colin Wallace, MSc., CAT (C)

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kevin K. Wang, Ph.D.

Participant discloses the following financial or non-financial relationships:

1. Banyan Biomarkers: Share holder

Participant has indicated no discussion of unapproved drug or product uses.

Dr Yang Wang, MD, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Sarah Wannez

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gale Whiteneck, PhD, FACRM

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christopher Thomas Whitlow, MD, PhD, MHA

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. John Whyte, MD, PhD

Participant discloses the following financial or non-financial relationships:

1. LifeMax, Inc.: consultant (fees turned over to employer)

Participant has indicated the following discussion of unapproved drug or product uses:

I intend to discuss the research evidence supporting a range of psychoactive drugs for patients with disorders of

consciousness. There are no labeled indications for this patient population so all treatments are "unlabeled."

Viona J.M. Wijnen, Dr.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Elisabeth Wilde, PhD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Dr.med. Dieter Heinrich Woischnek, M.D.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Hal Wortzel

Participant discloses the following financial or non-financial relationships:

1. Private practice in Forensic Neuropsychiatry : Private practice in Forensic Neuropsychiatry

Participant has indicated no discussion of unapproved drug or product uses.

Alexander Wright, M.Sc.

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

David Wright

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Tomofumi Yamaguchi, PT

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Giles Noel Yeates, BSc, MSc, DClinPsych

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ross Zafonte

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MSc. Sarah Zandvliet, PT

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Nathan Zasler, MD

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Roger Zemek, M.D., FRCPC

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Barbra Zupan

Participant has no financial or non-financial arrangements or affiliations to disclose.

Participant has indicated no discussion of unapproved drug or product uses.